MicroRNAs as Biomarker in Rheumatoid Arthritis: Pathogenesis to Clinical Relevance

Tooba Qamar1, Md Samsuddin Ansari2,3, Masihuddin4

  • 1Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, Uttar Pradesh, India.

PubMed

Insights

MicroRNAs (miRNAs) show potential as rheumatoid arthritis (RA) biomarkers, improving diagnosis and treatment. Machine learning integrates miRNA data for precise RA prediction and management, offering new hope for patients.

Area of Science:

  • Biochemistry and Molecular Biology
  • Immunology
  • Computational Biology

Background:

  • Rheumatoid arthritis (RA) diagnosis faces challenges due to low sensitivity and specificity of current biomarkers like rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA).
  • MicroRNAs (miRNAs) play crucial roles in RA pathogenesis, influencing inflammatory pathways and gene expression.
  • Specific miRNAs, including miR-146a, miR-155, miR-223, miR-126, and miR-24, are implicated in RA's inflammatory cascades and disease progression.

Purpose of the Study:

  • To explore the potential of miRNAs as diagnostic and prognostic biomarkers for rheumatoid arthritis (RA).
  • To investigate the role of specific miRNAs in RA pathogenesis and their modulation of the disease microenvironment.
  • To highlight the application of machine learning (ML) and artificial intelligence (AI) in integrating miRNA expression with clinical data for improved RA management.

Main Methods:

  • Analysis of miRNA expression patterns in the context of rheumatoid arthritis (RA).
  • Review of existing literature on the role of specific miRNAs (e.g., miR-146a, miR-155, miR-223, miR-126, miR-24) in RA.
  • Integration of miRNA expression data with clinical information using machine learning (ML) and artificial intelligence (AI) algorithms.

Main Results:

  • Certain miRNAs demonstrate potential as sensitive and specific biomarkers for RA diagnosis and prognosis.
  • miRNAs like miR-146a and miR-155 are involved in regulating inflammatory responses and joint damage in RA.
  • ML and AI models effectively integrate miRNA expression profiles with clinical data, enabling accurate predictions of RA onset, progression, and treatment response.

Conclusions:

  • miRNAs represent a promising avenue for precision medicine in rheumatoid arthritis (RA) management.
  • Overcoming challenges in miRNA validation, delivery, and off-target effects is crucial for clinical application.
  • The synergy of miRNA profiling and advanced computational approaches like ML/AI holds significant potential to revolutionize RA diagnosis, prognosis, and treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
12.4K